Contra-indicated in patients with known or suspected QT prolongation.
This product is not available in the European market.
- TRADE NAMES: Dehydrobenzperidol; Droleptan; Droperidol; Inapsin; Inapsine (Akorn); Sintodian; Xomolix (ProStrakan)
- INDICATIONS: Tranquilizer and antiemetic in surgical procedures
- CLASS: Antiemetic, Antipsychotic, Butyrophenone
- HALF-LIFE: 2.3 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Amiodarone, Amisulpride, Amitriptyline, Arsenic, Atomoxetine, Azithromycin, Chloroquine, CNS depressants, Cyclobenzaprine, Disopyramide, Duloxetine, Eszopiclone, Fluoxetine, Fluvoxamine, Hydromorphone, Hydroxychloroquine, Levomepromazine, Lurasidone, Macrolides, Metaxalone, Milnacipran, Moxifloxacin, Paliperidone, Pentamidine, Pimozide, QT prolonging agents, Quinine, Ramelteon, Sertraline, Sotalol, Sulpiride / levosulpiride, Tamoxifen, Tapentadol, Thiopental, Tiagabine, Tricyclic antidepressants
- See adverse reactions attributed to class:
QT PROLONGATION AND TORSADE DE POINTES
See full prescribing information for complete boxed warning.
Please login to view the rest of this drug profile.
Page last updated 08/07/2024
